Ward Shane 4
4 · Cidara Therapeutics, Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Ward Shane
COO & CLO
Transactions
- Sale
Common Stock
2024-03-11$0.67/sh−20,473$13,713→ 198,770 total
Footnotes (3)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.66 to $0.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 19, 2023 and November 20, 2023.